Clinical Trial Update: To Evaluate the Comparative Efficacy of Lucentis (Ranibizumab) 0.5mg Intravitreal Injection in Patients With Diabetic Macular Oedema (DME) With Well Controlled and Poorly Controlled Diabetes Mellitus [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing the efficacy of Lucentis (ranibizumab) 0.5 mg intravitreal injections in diabetic macular edema between patients with well-cont…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• Lucentis (ranibizumab)

Snippet

Sponsor: Marsden Eye Specialists | Conditions: Diabetic Macular Oedema | Phase 3 | Status: COMPLETED